All News Boditech Med Inc.

Equities

A206640

KR7206640005

End-of-day quote Korea S.E. Other stock markets 23:00:00 04/06/2024 BST			5-day change	1st Jan Change
17,500 ^KRW	-1.30%		-1.74%	-14.63%

02-21	4TEEN4 Pharmaceuticals GmbH announced that it has received funding from Boditech Med Inc.	CI
2023	Boditech Med Inc. and SphingoTec GmbH Enter into Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

4TEEN4 Pharmaceuticals GmbH announced that it has received funding from Boditech Med Inc.	02-20	CI
Boditech Med Inc. and SphingoTec GmbH Enter into Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid	31/08/23	CI
MENARINI ANNOUNCES AN EXCLUSIVE DISTRIBUTION AGREEMENT FOR BODITECH'S AFIAS-10 SYSTEM	20/04/23	AQ
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.	28/03/23	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.	28/03/23	CI
Boditech Med Inc.'s Equity Buyback announced on September 29, 2022, has expired with 496,620 shares, representing 2.21% for KRW 4,994.56 million	27/03/23	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.	29/12/22	CI
Boditech Med Inc. and SphingoTec GmbH Enters into Non-Exclusive Royalty-Bearing License Agreement	15/11/22	CI
Boditech Med Inc. announces an Equity Buyback for KRW 5,000 million worth of its shares.	29/09/22	CI
Boditech Med Inc. authorizes a Buyback Plan.	28/09/22	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.	13/06/22	CI
Boditech Med Inc.'s Equity Buyback announced on December 14, 2021, has expired with 297,901 shares, representing 1.31% for KRW 4,987.06 million.	12/06/22	CI
Novo Integrated Sciences, Boditech Med Sign Memorandum of Understanding for Distribution of Diagnostic Technologies	29/03/22	MT
Novo Integrated Sciences, Inc. Signs Memorandum of Understanding with Boditech Med to Market and Distribute in North America	29/03/22	CI
Boditech Med Announces the Formation of a U.S. Based Advisory Board and its First Member, Zachariah P. Zachariah, M.D	24/03/22	CI
Boditech Med Partners with Novo Integrated Sciences, Inc. to Market and Distribute Lower-Cost, Rapid Testing in North America	22/03/22	CI
Boditech Med to Expand to U.S., North America	18/03/22	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.	14/03/22	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 6, 2021.	04/03/22	CI
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 6, 2021.	04/03/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Boditech Med Inc.

Equities

A206640

KR7206640005

All News

Filters